Navigation Links
JumpStart Invests in Tursiop Technologies
Date:6/19/2008

CLEVELAND, June 19 /PRNewswire/ -- JumpStart Inc., the Northeast Ohio venture development organization that accelerates the growth of innovative early-stage businesses and ideas, has announced an investment commitment of $350,000 in Cleveland-based Tursiop Technologies, LLC. The JumpStart investment is part of a recently closed investment round that included $1 million from RMS Management of Cleveland, OH.

(Logo: http://www.newscom.com/cgi-bin/prnh/20060209/CLJUMPSTARTLOGO )

Tursiop is developing a novel nanomaterial-based coil for magnetic resonance scanners. This new type of coil will bring fundamental change to the MRI market through its improved image quality, compared to conventional coil technologies. Targeting a projected billion dollar market by 2012, Tursiop has already built, tested, and generated images with several prototype coils. These coils have outperformed conventional coils and the Tursiop team, including CEO Brad Goldstein, believes that with additional development further significant gains will be achieved.

"Our patent-pending technology is based on a fundamental change in the way the coils are designed and manufactured," said Goldstein. "We at Tursiop are excited to be at the nexus of medical imaging and nanotechnology and look forward to providing clinicians the means to enhance the diagnosis and treatment of some of the major health concerns of our time, including heart disease, neurological disorders, and cancer."

JumpStart Entrepreneur-in-Residence Kevin Mendelsohn will be working with the company. "MRI scanners and coils are mature technologies that have experienced only incremental change over the past 10 to 15 years," Mendelsohn said. "Currently, the most effective method of improving image quality is through increased magnet strength, which is a costly alternative. The other is through the use of specialty coils, but when compared to increased magnet strength, the improvement has been relatively small. Tursiop's coils offer improved imaging performance comparable to that of a more powerful scanner, but at a much lower cost," he concluded.

With the close of this investment round, Tursiop plans to establish office and laboratory spaces, continue research and product development, and begin the FDA approval process.

This is JumpStart's 41st investment in its 30th company. Other healthcare companies in JumpStart's portfolio include AcelleRX Therapeutics, AnalizaDx, CardioInsight Technologies, CerviLenz, Great Lakes Pharmaceuticals, Synapse Biomedical and Telerad Express.

About Tursiop Technologies, LLC

Tursiop Technologies is developing revolutionary MRI coil devices utilizing proprietary nanotechnology, which will produce higher image quality and faster scan times resulting in a significant boost of the functional capabilities of any installed MRI system. Tursiop-generated imaging enhancements will apply across the entire range of MRI system field strengths, from low-field to high-field systems. Increased diagnostic competency will lead to improved patient outcomes and open the doors to new therapeutic opportunities within the areas of interventional, intra-operative and functional MRI and molecular imaging.

About RMS Management

RMS Management is an integrated family office that was formed in 1991 and is comprised of a diverse group of individuals and institutions providing financial and personal services to the founding families of a publicly traded real estate company. The company strives to enhance the professional and personal goals and objectives of every generation of the Ratner, Miller and Shafran families.

About JumpStart Inc.

JumpStart ( http://www.jumpstartinc.org ) accelerates the growth of innovative early-stage businesses and ideas into venture-ready companies by delivering vital, focused resources to entrepreneurs and the community of Northeast Ohio. JumpStart identifies and invests in early-stage companies that have strong potential in the marketplace, solid prospects for high growth, and are likely to qualify for later-stage funding. Beyond investing, the JumpStart team provides a continuum of business development services to its client companies to help ensure their success.


'/>"/>
SOURCE JumpStart Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. JIC Invests in Three New Alternative Energy Projects
2. Powersafe Technology Corp. Recapitalizes, Executes Merger Agreement with Amplification Technologies, and Invests in Amplification
3. Roche Molecular Diagnostics Invests $57.5 Million in Green Research Building
4. The Pittsburgh Life Sciences Greenhouse Invests $100,000 in ParentPlus
5. The PLSG Invests $115,000 in Innovention Technologies, LLC
6. The PLSG Invests $150,000 in Coventina Healthcare Enterprises, Inc., Its Eighth Company Relocation to Pittsburgh
7. Applied Computational Technologies Appoints a New CEO
8. PAL Health Technologies Debuts Xtremityscan System at Western Podiatric Medical Congress
9. Senesco Technologies to Present at BIO 2008 Business Forum
10. BioSpecifics Technologies Corp. Announces Additional Sales of Stock in Private Placement Offering
11. Spine Surgeons at Pine Creek Medical Center Take the Lead in Utilizing Stem Cell Technologies in Surgical Procedures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016  Global demand for ... percent through 2020 to $7.2 billion.  This market ... beverages, cleaning products, biofuel production, animal feed, and ... diagnostics, and biocatalysts). Food and beverages will remain ... by increasing consumption of products containing enzymes in ...
(Date:6/27/2016)... ... 2016 , ... Newly created 4Sight Medical Solutions ... healthcare market. The company's primary focus is on new product introductions, to include ... are necessary to help companies efficiently bring their products to market. , The ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
Breaking Biology Technology:
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:3/31/2016)... 31, 2016  Genomics firm Nabsys has completed a ... Barrett Bready , M.D., who returned to the company ... technical leadership team, including Chief Technology Officer, John ... Steve Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys ...
Breaking Biology News(10 mins):